10.1038/s41598-021-97967-0 Summary Keywords heart failure, GLP-1, glucagon-like peptide-1, clinical trials, cardiovascular disease, cardiovascular outcome studies, diabetes, obesity Citation Kreiner FF, Hovingh GKK and von Scholten BJ (2022) The potential of glucagon-like peptide-1 receptor agonists in heart failure
One missed injection doesnt mean a trip to the hospital or the end of your weight loss journey
In vitro embryo production in Sheep
Sexual health: As estrogen levels decrease, it can cause problems with vaginal health like dryness, thinning of the vaginal walls, and discomfort during sex
YG: Writing review & editing